Clinical trials recruiting in Shatin, New Territories, Hong Kong

Phase breakdown

Conditions recruiting in Shatin, New Territories, Hong Kong

Recruiting trials in Shatin, New Territories, Hong Kong

• A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
  NCT07005128 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female)
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Shatin, New Territories, Hong Kong?

3 recruiting trials have at least one study site in Shatin, New Territories, Hong Kong.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.